New developments in the treatment of anxiety disorders.
D014151:Anti-Anxiety Agents / Q000009:adverse effects / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy*; D001569:Benzodiazepines; D002065:Buspirone / Q000627:therapeutic use; D006801:Humans; D012017:Referral and Consultation
D014151:Anti-Anxiety Agents; D000929:Antidepressive Agents, Tricyclic; D001569:Benzodiazepines; D002065:Buspirone